Clinical Trial Update: A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 study evaluating the safety and tolerability of Acthar in patients with amyotrophic lateral scleros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Acthar (repository corticotropin injection)

Snippet

Sponsor: Mallinckrodt | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2017-01-06